최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Cancer research and treatment : official journal of Korean Cancer Association, v.47 no.4, 2015년, pp.591 - 599
Shin, Dong Wook (Department of Family Medicine & Health Promotion Center, Seoul National University Hospital, Seoul, Korea) , Cho, Juhee (Department of Health, Behavior and Society & Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA) , Yang, Hyung Kook (Division of Cancer Policy and Management, National Cancer Control Institute, National Cancer Center, Goyang, Korea) , Kim, So Young (Division of Cancer Policy and Management, National Cancer Control Institute, National Cancer Center, Goyang, Korea) , Lee, Su Hyun (Department of Hemato-Oncology, Yonsei Cancer Center, Severance Hospital, Seoul, Korea) , Suh, Beomseok (Department of Family Medicine & Health Promotion Center, Seoul National University Hospital, Seoul, Korea) , Shin, Hee-Young (Department of Biomedical Science, Chonnam National University Medical School and Clinical Trial Center, Chonnam National University Hospital, Gwangju, Korea Korea<) , Lee, Hyun Joo , Kim, Dae Ghon , Park, Jong Hyock
PurposeIn response to the challenges and difficulties imposed by rare cancers, multi-stakeholder initiatives dedicated to improving rare cancer care was launched, and several recommendations were made by professional societies. However, these primarily reflect the view of the advocates and supporter...
1 Greenlee RT Goodman MT Lynch CF Platz CE Havener LA Howe HL The occurrence of rare cancers in U.S. adults, 1995-2004 Public Health Rep 2010 125 28 43 20402194
2 National Cancer Institute Epidemiology and Genetics Research Synergizing epidemiologic research on rare cancers [Internet] Bethesda National Cancer Institute Epidemiology and Genetics Research 2007 [cited 2014 Feb 1]. Available from: http://epi.grants.cancer.gov/workshops/synergizing/
3 Gatta G van der Zwan JM Casali PG Siesling S Dei Tos AP Kunkler I Rare cancers are not so rare: the rare cancer burden in Europe Eur J Cancer 2011 47 2493 511 22033323
4 Schaefer R Rare Cancers Europe: joining forces to tackle a common problem Rare Tumors 2012 4 e24 22826781
5 de Vrueh R Baekelandt ER de Hann JM Update on 2004 background paper: BP 6.19 rare diseases Geneva World Health Organization 2013
6 Gatta G Ciccolallo L Kunkler I Capocaccia R Berrino F Coleman MP Survival from rare cancer in adults: a population-based study Lancet Oncol 2006 7 132 40 16455477
7 Redmond K Rare cancers in Europe: tackling a common problem [Internet] ESO 2009 [cited 2014 Feb 1]. Available from: http://www.cancerworld.org/articles/issues_33/editorial/rare_cancers_in_europe_-_tackling_a_common_problem.html
8 Shin DW Park JH Shim EJ Hahm MI Park JH Park EC Predictors and outcomes of feeling of insufficient consultation time in cancer care in Korea: results of a nationwide multicenter survey Support Care Cancer 2012 20 1965 73 22068384
9 European Society for Medical Oncology Improving rare cancer care in Europe: recommendations on stakeholder actions and public policies [Internet] Viganello-Lugano European Society for Medical Oncology c2010 [cited 2014 Feb 1]. Available from: http://www.esmo.org/content/download/16802/296577/file/improving-rare-cancer-care-europerecommendations-2010.pdf
10 Lenaerts L Remue E Otter R van Hoof E Evaluation of the cancer plan 2008-2010: results 2011. Scientific Insititute fo Public Health, Cancer Centre [Internet] Brussel Kankercentrum Centre du Cancer 2012 [cited 2014 Feb 1]. Available from: https://workspaces.wiv-isp.be/e-cancer/PublicFiles/presentations/Belgian_Cancer_Center/Quantitative_evaluation_Cancer_Plan_Results%202011_EN.pdf
11 Burls A Austin D Moore D Commissioning for rare diseases: view from the frontline BMJ 2005 331 1019 21 16254306
12 Simoens S Cassiman D Dooms M Picavet E Orphan drugs for rare diseases: is it time to revisit their special market access status? Drugs 2012 72 1437 43 22747423
13 Picavet E Cassiman D Simoens S Evaluating and improving orphan drug regulations in Europe: a Delphi policy study Health Policy 2012 108 1 9 22989856
14 Abelson R Pollack A Medicare widens drugs it accepts for cancer [Internet] New York The New York Times 2009 [cited 2014 Feb 1]. Available from: http://www.nytimes.com/2009/01/27/health/27cancer.html?pagewanted=all&_r=0
15 Dockser Marcus A To make progress in rare cancers, patients must lead the way J Clin Oncol 2009 27 2575 7 19414666
16 Commission of the European Communities Communication from the commission to the European parliament, the council, the European economic and social committee and the committee of the regions. On rare diseases: Europe's challenges [Internet] Brussels Commission of the European Communities 2008 [cited 2014 Feb 1]. Available from: http://ec.europa.eu/health/ph_threats/non_com/docs/rare_com_en.pdf
17 Denis A Mergaert L Fostier C Cleemput I Simoens S A comparative study of European rare disease and orphan drug markets Health Policy 2010 97 173 9 20800761
18 EURODIS The voice of rare disease patients: experiences and expectations of over 3,000 patients on rare disease patient registries in Europe [Internet] Brussels EURODIS 2013 [cited 2014 Feb 1]. Available from: http://www.eurordis.org/
19 HemOnc Today Lack of guidelines, clinical data complicate treatment of rare cancers [Internet] HemOnc Today 2012 [cited 2014 Feb 1]. Available from: http://www.healio.com/hematology-oncology/news/print/hematology-oncology/%7B1b579909-7aef-4f86-bd98-d8c3ea6d9d3e%7D/lackof-guidelines-clinical-data-complicate-treatment-of-rarecancers
20 Jung KW Won YJ Kong HJ Oh CM Seo HG Lee JS Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010 Cancer Res Treat 2013 45 1 14 23613665
21 The Council of the European Union Council recommendation of 8 June 2009 on an action in the field of rare disease (2009/C 151/02) [Internet] Viganello-Lugano The Council of the European Union 2009 [cited 2014 Feb 1]. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2009:151:0007:0010:EN:PDF
22 Blue Cross Blue Shiled Association Blue Distinction Centers for Complex and Rare Cancers (Focusing on complex inpatient and surgical care) [Internet] Blue Cross Blue Shiled Association 2014 [cited 2014 Feb 1]. Available from: http://www.arkansasbluecross.com/providers/BDCancers.aspx
23 Derrow P When you’re diagnosed with a rare cancer [Internet] New York NBC News 2010 [cited 2014 Feb 1]. Available from: http://www.nbcnews.com/id/36182363/ns/healthcancer/t/when-youre-diagnosed-rare-cancer/
24 Peppercorn J Burstein H Miller FG Winer E Joffe S Self-reported practices and attitudes of US oncologists regarding off-protocol therapy J Clin Oncol 2008 26 5994 6000 19029413
25 American Society of Clinical Oncology Reimbursement for cancer treatment: coverage of off-label drug indications J Clin Oncol 2006 24 3206 8 16717290
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.